A third phase of the polio vaccination campaign is set to begin tomorrow in part of the northern Gaza Strip after being postponed from 23 October 2024 due to lack of access and assured, comprehensive humanitarian pauses, intense bombardment, and mass evacuation orders.
Almost a year since Humira biosimilars launched, AbbVie still controls more than 97% of the US market
AbbVie isn’t losing its control of its biggest cash cow Humira (adalimumab) quite yet, despite the influx of eight adalimumab biosimilars vying for market share,